You are here: Industry Insights > CDMO

News List

WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership prnasia
May 27, 2021
WuXi Biologics, a global company with leading open-access biologics technology platforms, and OncoC4, Inc., a privately-held, clinical-stage biopharmaceutical company, today announced that the companies have entered into an exclusive contract ...
Clean Biologics buys CDMO Biodextris cphi-online
May 27, 2021
Transaction enables ArchiMed-backed biopharmaceutical services group to establish North American presence and expand activities with complementary services
Tergus Pharma Opens New HQ & Commercial Manufacturing Facility contractpharma
May 26, 2021
Tergus Pharma, a topical contract development and manufacturing organization (CDMO), officially opened its new, 100,000 sq. ft. headquarters and commercial manufacturing facility with a ribbon-cutting ceremony on May 13, 2021.
CDMO sector are the big winner of the pandemic, state experts europeanpharmaceuticalreview
May 25, 2021
In a presentation, experts revealed that contract services gained significantly through pandemic contracts but cautioned that capacity shortages could continue.
Recro Pharma, Astex Enter Drug Development Alliance contractpharma
May 19, 2021
Recro Pharma, Inc., a CDMO providing services for complex formulation and manufacturing challenges for oral solid dose drug products, has signed a new development agreement with Astex Pharmaceuticals, Inc.
Mycenax becomes Taiwan, China's first CDMO company to complete the CHO-S and CHOZN GS Cell Line Development with the Beacon(R) Optofluidic System prnasia
May 18, 2021
Mycenax becomes one of the first CDMO companies in Asia to adapt the Beacon Optofluidic system to cell line development services.
Charles River to Acquire Vigene Biosciences contractpharma
May 18, 2021
Charles River Laboratories International Inc. has signed a definitive agreement to acquire Vigene Biosciences Inc., a premier, U.S.-based gene therapy contract development and manufacturing organization (CDMO) providing viral vector-based gene ...
WuXi Biologics and WuXi STA Jointly Established WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services prnasia
May 14, 2021
WuXi Biologics, a global company with leading open-access biologics technology platforms, and WuXi STA, a subsidiary of WuXi AppTec, today announced that a joint venture company named WuXi XDC was established to provide end-to-end contract development ...
Applying Agile methodologies in CDMOs expresspharma
May 14, 2021
In order to truly help biotech and pharma companies in their journey from drug development to commercialisation, contract development and manufacturing organisations (CDMOs) have begun to incorporate the latest innovations in all aspects of their ...
Vetter, Rentschler Biopharma Advance Strategic Alliance contractpharma
April 29, 2021
Rentschler Biopharma and Vetter, two global CDMOs, have advanced their strategic collaboration, establishing a framework for their alliance and set up a governance structure, as well as implemented guidelines for their joint approach across functions.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page